These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1914782)

  • 21. Idiopathic apnoea of prematurity treated with doxapram and aminophylline.
    Sagi E; Eyal F; Alpan G; Patz D; Arad I
    Arch Dis Child; 1984 Mar; 59(3):281-3. PubMed ID: 6424586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Post-dosage loading concentrations of theophylline and pharmacokinetic study after the fifth maintenance dosage in premature newborns with apnea].
    Rodríguez-Palomares C; Udaeta-Mora E; González-Treviño J; Juárez-Olguín H; Calderón-Mandujano B; Prado-Serrano A; Belmont-Gómez A
    Bol Med Hosp Infant Mex; 1991 Mar; 48(3):164-72. PubMed ID: 2064746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of neonatal apnea.
    Merchant RH; Irani AJ
    Indian Pediatr; 1991 Nov; 28(11):1358-62. PubMed ID: 1808070
    [No Abstract]   [Full Text] [Related]  

  • 24. [Monitoring theophylline in premature newborn infants].
    Closa RM; Tarres Roure A; Gómez Papi A; Casasin Edo T
    An Esp Pediatr; 1989 Apr; 30(4):269-71. PubMed ID: 2742236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A comparison of the efficacy of aminophylline and doxapram in preventing idiopathic apnea in preterm newborn infants].
    Romeo MG; Proto N; Tina LG; Parisi MG; Distefano G
    Pediatr Med Chir; 1991; 13(1):77-81. PubMed ID: 2052460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Apnea and theophylline in the premature infant. Clinical and pharmacokinetic study in 32 premature infants].
    Cottancin G; Sann L; Bory B; Bourgeois J; Frederich A; Baltassat P; Bethenod M
    Pediatrie; 1981 Mar; 36(2):91-101. PubMed ID: 7232073
    [No Abstract]   [Full Text] [Related]  

  • 27. CO(2) inhalation as a treatment for apnea of prematurity: a randomized double-blind controlled trial.
    Alvaro RE; Khalil M; Qurashi M; Al-Saif S; Al-Matary A; Chiu A; Minski J; Manfreda J; Kwiatkowski K; Cates D; Rigatto H
    J Pediatr; 2012 Feb; 160(2):252-257.e1. PubMed ID: 21907349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determinants of doxapram utilization: a survey of practice in the French Neonatal and Intensive Care Units].
    Bénard M; Boutroy MJ; Glorieux I; Casper C
    Arch Pediatr; 2005 Feb; 12(2):151-5. PubMed ID: 15694538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain hemodynamic effects of doxapram in preterm infants.
    Dani C; Bertini G; Pezzati M; Pratesi S; Filippi L; Tronchin M; Rubaltelli FF
    Biol Neonate; 2006; 89(2):69-74. PubMed ID: 16158005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of transdermal theophylline pharmacokinetics in neonates.
    Micali G; Bhatt RH; Distefano G; Caltabiano L; Cook B; Fischer JH; Solomon LM; West DP
    Pharmacotherapy; 1993; 13(4):386-90. PubMed ID: 8361866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oral administration of doxapram in preterm neonates with aminophylline-resistant idiopathic apnea crisis].
    Romeo MG; Betta P; Tina LG; Cilauro S; Saporito A; Distefano G
    Pediatr Med Chir; 1995; 17(2):123-6. PubMed ID: 7610073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of doxapram in low-birth-weight Japanese infants with apnea.
    Ogawa Y; Irikura M; Kobaru Y; Tomiyasu M; Kochiyama Y; Uriu M; Ishitsuka Y; Kondo Y; Yukawa E; Kamada N; Ohno H; Yamazaki T; Irie T
    Eur J Pediatr; 2015 Apr; 174(4):509-18. PubMed ID: 25248340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxapram for the initial treatment of idiopathic apnea of prematurity.
    Bairam A; Faulon M; Monin P; Vert P
    Biol Neonate; 1992; 61(4):209-13. PubMed ID: 1610948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiologic effects of doxapram in idiopathic apnea of prematurity.
    Barrington KJ; Finer NN; Peters KL; Barton J
    J Pediatr; 1986 Jan; 108(1):124-9. PubMed ID: 3080569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting theophylline pharmacokinetics in premature infants with apnea.
    Hilligoss DM; Jusko WJ; Koup JR; Giacoia G
    Dev Pharmacol Ther; 1980; 1(1):6-15. PubMed ID: 7438966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic concentrations of theophylline and caffeine during treatment of apnea in premature infants with theophylline].
    Alix D; Berthou F; Riche C; Gouedard H
    Arch Fr Pediatr; 1985; 42(6):465-9. PubMed ID: 4051680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of theophylline versus CO2 inhalation for treating apnea of prematurity.
    Al-Saif S; Alvaro R; Manfreda J; Kwiatkowski K; Cates D; Qurashi M; Rigatto H
    J Pediatr; 2008 Oct; 153(4):513-8. PubMed ID: 18534618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability of salivary theophylline in monitoring the treatment for apnoea of prematurity.
    Chereches-Panta P; Nanulescu MV; Culea M; Palibroda N
    J Perinatol; 2007 Nov; 27(11):709-12. PubMed ID: 17717520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxapram in the treatment of idiopathic apnea of prematurity: desirable dosage and serum concentrations.
    Hayakawa F; Hakamada S; Kuno K; Nakashima T; Miyachi Y
    J Pediatr; 1986 Jul; 109(1):138-40. PubMed ID: 3723234
    [No Abstract]   [Full Text] [Related]  

  • 40. Doxapram Dosing for Apnea of Prematurity Based on Postmenstrual Age and Gender: A Randomized Controlled Trial.
    Greze E; Benard M; Hamon I; Casper C; Haddad FE; Boutroy MJ; Hascoët JM
    Paediatr Drugs; 2016 Dec; 18(6):443-449. PubMed ID: 27612991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.